CYBN logo

Cybin
CYBN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$296.93M
EV
$242.06M
Shares Outstanding
49.90M
Beta
1.09
Industry
Biotechnology

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
6
P/E 2026E
-
P/Revenue 2026E
-

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2026E
-
Net Profit Margin 2026E
-
ROE 2026E
-68.10%
ROCE 2025
-42.76%

Dividends

DPS 2026E
-
Payout Ratio 2026E
-
Div. Yield 2026E
-
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Cybin Inc.

gainify
CYBN logo

Cybin Inc.

CYBN

Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. The company’s development pipeline includes CYB003, a deuterated psilocybin analog, which is in phase 1/2a clinical...

Sector

Healthcare

Industry

Biotechnology

CEO

Drysdale, Douglas

Employees

50

IPO Date

2019-09-13

Headquarters

100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9, Canada

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.